Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=15

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01252953-53e71dd8",
        "title": "Anacetrapib vs Placebo Anacetrapib: Number of Participants With Major Atherosclerotic Event",
        "summary": "1383 of 15225 against 1483 of 15224; risk difference -0.7 points, 95% interval -1.3 to -0.0; NCT01252953, REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification",
        "record": "/library/comparisons/NCT01252953-53e71dd8",
        "nct_id": "NCT01252953",
        "kind": "outcome",
        "participants": 30449,
        "risk_difference": {
          "value": -0.006574542658856,
          "lower": -0.01313720165773967,
          "upper": -0.000014081461120689365
        },
        "group_1": "1,383 of 15,225",
        "group_2": "1,483 of 15,224",
        "difference": "-0.7 points",
        "interval": "-1.3 to -0.0",
        "trial_title": "REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification"
      },
      {
        "id": "NCT01252953-752ae211",
        "title": "Anacetrapib vs Placebo Anacetrapib: Number of Participants With Major Vascular Event",
        "summary": "2068 of 15225 against 2214 of 15224; risk difference -1.0 points, 95% interval -1.7 to -0.2; NCT01252953, REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification",
        "record": "/library/comparisons/NCT01252953-752ae211",
        "nct_id": "NCT01252953",
        "kind": "outcome",
        "participants": 30449,
        "risk_difference": {
          "value": -0.009599042907793148,
          "lower": -0.017408970737240945,
          "upper": -0.0017893622338692886
        },
        "group_1": "2,068 of 15,225",
        "group_2": "2,214 of 15,224",
        "difference": "-1.0 points",
        "interval": "-1.7 to -0.2",
        "trial_title": "REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=16",
  "request_id": "ElHnQnCz8B0MVU6I"
}